How Justices May Be Leaning In Amgen Argument

Law360, New York (December 12, 2012, 1:29 PM EST) -- Must a plaintiff in a securities fraud class action prove that the alleged misrepresentations or omissions are material in order to obtain class certification? That is the issue the United States Supreme Court considered when it heard oral argument in an appeal from the Ninth Circuit Court of Appeals, Connecticut Retirement Plans and Trust Fund v. Amgen, 660 F.3d 1170 (9th Cir. 2011), cert. granted sub. nom, Amgen Inc. v. Connecticut Retirement Plans and Trust Funds, No. 11-1085 (U.S. Sup. Ct. argued Nov. 6, 2012)....
To view the full article, register now.